Kappa Free Light Chains (KFLC) in Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS)
This research study aims to understand the role of a specific marker called kappa free light chains (KFLC) found in the fluid surrounding your brain and spinal cord (cerebrospinal fluid, or CSF). The main goal is to see if measuring KFLC can help doctors diagnose multiple sclerosis (MS) and clinically isolated syndrome (CIS). This study compares KFLC to another common test called oligoclonal bands, which is currently the gold standard for diagnosing these conditions using CSF. We want to find out if KFLC measurements are equally useful, more useful, or less useful than oligoclonal bands in identifying MS and CIS. Researchers will look at samples from patients who have already been diagnosed with MS or CIS.
At a glance
What is this study about?
This study is looking into ways to improve how doctors diagnose conditions like multiple sclerosis (MS) and clinically isolated syndrome (CIS). MS is a condition that affects your brain and spinal cord, leading to various symptoms. CIS is often the first episode of symptoms similar to MS, but it doesn't yet meet the full criteria for an MS diagnosis.
Currently, one of the main ways doctors get more information for diagnosing these conditions is by looking at a sample of the fluid that surrounds your brain and spinal cord, called cerebrospinal fluid (CSF). They often look for something called 'oligoclonal bands.' This study introduces another marker, called 'kappa free light chains' (KFLC), and compares it to oligoclonal bands.
Researchers want to see if KFLC can be a good tool for diagnosis. They will look at CSF samples from people already diagnosed with MS or CIS and compare the results of both tests. This will help them understand if KFLC is as reliable, more reliable, or less reliable than the current standard test. The study will also help establish clearer guidelines for what normal KFLC levels should be, as this isn't yet fully agreed upon.
Key takeaways
- This study compares two tests for MS/CIS diagnosis: Kappa Free Light Chains (KFLC) and Oligoclonal Bands.
- It aims to see if KFLC is as good as, better than, or worse than the current standard test.
- The research uses samples of spinal fluid (CSF) and blood from patients with MS or CIS.
- Participation involves reviewing your medical records and existing samples, not new treatments.
- The study helps establish clearer guidelines for diagnosing these conditions in the future.
Who may be eligible?
To take part in this study, you would need to have already been diagnosed with multiple sclerosis (MS) or clinically isolated syndrome (CIS). These diagnoses must follow specific guidelines known as the 2017-revised McDonald criteria for MS.
Participants must be between the ages of 18 and 70 years old.
You would not be able to join the study if you haven't received an MS or CIS diagnosis that meets the specific criteria, or if fluid samples from your spine (CSF) and blood are not available for the researchers to test.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I have been diagnosed with Multiple Sclerosis (MS) or Clinically Isolated Syndrome (CIS).
- My diagnosis follows the 2017-revised McDonald criteria for MS.
- I am between 18 and 70 years old.
- I have had samples of fluid from my spine (CSF) and blood taken.
What does participation involve?
This is an observational study, which means you won't be given any new medications or treatments. The researchers will be looking at information and samples that have already been, or will be, collected as part of your regular medical care. This includes pairs of spinal fluid (CSF) and blood samples.
If you take part, the researchers will analyse these samples for particular markers, specifically oligoclonal bands and kappa free light chains (KFLC). They will also look at your medical records and track your health over time to see if your condition changes or progresses. The study aims to follow participants for a period to observe how their condition develops.
Potential risks and benefits
Locations (1)
- Medizinische Hochschule Hannover / Hannover Medical SchoolVerified postcodeHanover, Germany
Common questions
What are kappa free light chains (KFLC)?
KFLC are tiny bits of protein found in your body, and researchers are studying if they can help doctors diagnose conditions like MS using fluid from your spine.
What is 'cerebrospinal fluid' (CSF)?
CSF is the clear fluid that surrounds and protects your brain and spinal cord. Doctors can take a small sample to help diagnose certain conditions.
What is 'clinically isolated syndrome' (CIS)?
CIS is usually the first time someone experiences symptoms similar to MS, but it doesn't yet fully meet the criteria for a definite MS diagnosis.
Will I receive any new treatments in this study?
No, this study is observational. It means researchers are looking at information and samples already collected as part of your regular care, not giving new treatments.
How long will the study last for me?
The study involves looking at your samples and medical information over time, following your condition's progress. Your clinical team can provide more specific details.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.